Abstract:Importance: Cognitive functioning is associated with various factors, such as age, sex, education, and childhood adversity, and is impaired in people with psychosis. In addition to specific effects of the disorder, cognitive impairments may reflect a greater exposure to general risk factors for poor cognition. Objective: To determine the extent that impairments in cognition in psychosis reflect risk factor exposures. Design, setting, and participants: This cross-sectional study examined the relationship between exposures and cognitive function using data from the Bipolar-Schizophrenia Network on Intermediate Phenotypes studies 1 and 2 across 6 sites. Participants included healthy controls; patients with schizophrenia, schizoaffective disorder, or bipolar I disorder with psychosis; and relatives of patients. Predictive modeling was performed using extreme gradient boosting regression to train a composite cognitive score prediction model with nested cross-validation. Shapley additive explanations values were used to examine the relationship between exposures and cognitive function. Exposure: Exposures were chosen based on associations with cognition previously identified: age, sex, race and ethnicity, childhood adversity, education, parental education, parental socioeconomic status, parental age at birth, substance use, antipsychotic dose, and diagnosis. Main outcomes and measures: Cognition was assessed using the Brief Assessment of Cognition in Schizophrenia. Results: A total of 3370 participants were included: 840 healthy controls, 709 patients with schizophrenia, 541 with schizoaffective disorder, 457 with bipolar I disorder with psychosis, and 823 relatives of patients. The mean (SD) age was 37.9 (13.3) years; 1887 were female (56%) and 1483 male (44%). The model predicted cognitive scores with high accuracy: out-of-sample Pearson correlation between predicted and observed cognitive composite score was r = 0.72 (SD = 0.03). Individuals with schizophrenia (z = -1.4), schizoaffective disorder (z = -1.2), and bipolar I disorder with psychosis (z = -0.5) all had significantly worse cognitive composite scores than controls. Factors other than diagnosis and medication accounted for much of this impairment (schizophrenia z = -0.73, schizoaffective disorder z = -0.64, bipolar I disorder with psychosis z = -0.13). Diagnosis accounted for a lesser proportion of this deficit (schizophrenia z = -0.29, schizoaffective disorder z = -0.15, bipolar I disorder with psychosis z = -0.13), and antipsychotic use accounted for a similar deficit across diagnostic groups (schizophrenia z = -0.37, schizoaffective disorder z = -0.33, bipolar I disorder with psychosis z = -0.26). Conclusions and relevance: This study found that transdiagnostic factors accounted for a meaningful share of the variance in cognitive functioning in psychosis. A significant proportion of the cognitive impairment in psychosis may reflect factors relevant to cognitive functioning in the general population. When considering interventions, a diagnosis-agnostic, symptom-targeted approach may therefore be appropriate.

Major Neurocognitive Psychosis: a Novel Schizophrenia Endophenotype Class That is Based on Machine Learning and Resembles Kraepelin's and Bleuler's Conceptions.

Towards a New Classification of Stable Phase Schizophrenia into Major and Simple Neuro-Cognitive Psychosis: Results of Unsupervised Machine Learning Analysis

The Negative Symptoms of Schizophrenia: Lessons from a Precision Nomothetic Psychiatry Approach

The novel pathway phenotype “major neurocognitive psychosis” is validated as a distinct class through the analysis of immune-linked neurotoxicity biomarkers and neurocognitive deficits

The novel schizophrenia subgroup "major neurocognitive psychosis" is validated as a distinct class through the analysis of immune-linked neurotoxicity biomarkers and neurocognitive deficits

The Neuroimmune and Neurotoxic Fingerprint of Major Neurocognitive Psychosis or Deficit Schizophrenia: a Supervised Machine Learning Study

How to Construct a Bottom-up Nomothetic Network Model and Disclose Novel Nosological Classes by Integrating Risk Resilience and Adverse Outcome Pathways with the Phenome of Schizophrenia

Precision Nomothetic Medicine in Depression Research: A New Depression Model, and New Endophenotype Classes and Pathway Phenotypes, and A Digital Self

Associations between psychosis endophenotypes across brain functional, structural, and cognitive domains.

M61. Data-Driven Approach Identified Functionally and Physiologically Distinct Psychosis Subtypes

205. Machine Learning to Further Improve Classification of Psychotic Disorders Using Clinical and Biological Stratification: Updates from the Bipolar Schizophrenia Network for Intermediate Phenotypes (BSNIP)

Construction of a Neuro-Immune-Cognitive Pathway-Phenotype Underpinning the Phenome of Deficit Schizophrenia

Neuroimaging Defined Psychosis Spectrum Phenotypes in the General Population

Towards a new model and classification of mood disorders based on risk resilience, neuro-affective toxicity, staging, and phenome features using the nomothetic network psychiatry approach

Deconstructing Cognitive Impairment in Psychosis With a Machine Learning Approach

From the Laboratory to the Real-World: The Role of Mismatch Negativity in Psychosis

Schizophrenia Phenomenology Revisited: Positive and Negative Symptoms Are Strongly Related Reflective Manifestations of an Underlying Single Trait Indicating Overall Severity of Schizophrenia

Heterogeneity and Classification of Recent Onset Psychosis and Depression: A Multimodal Machine Learning Approach

How to construct neuroscience-informed psychiatric classification? Towards nomothetic networks psychiatry

Supervised Machine Learning Classification of Psychosis Biotypes Based on Brain Structure: Findings from the Bipolar-Schizophrenia Network for Intermediate Phenotypes (B-SNIP).

Neurocognitive profiles in the prodrome to psychosis in NAPLS-1